Despite research of proposed mechanisms of the anti-proliferative effects of HDAC inhibitors on lymphoid malignancies [14,15], the exact effects and mechanisms in DLBCL remain unclear. Here, HDAC9 is linked to diffuse large B-cell lymphoma.